U.S. biotechs, pharmas can learn from China to accelerate drug development

3 weeks ago 2

• Healthcare

STAP

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger pharma companies, including those that are U.S.-based, provide an example for U.S. biotechs and pharmas to follow.

Speaking during a session at

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. U.S. biotechs, pharmas can learn from China to accelerate drug development